Evidence map›Paper›PMID 31336989›Full record

ReviewMetabolites2019

Statistical Workflow for Feature Selection in Human Metabolomics Data.

Joseph Antonelli, Brian L Claggett, Mir Henglin, Andy Kim, Gavin Ovsak, Nicole Kim, Katherine Deng, Kevin Rao, Octavia Tyagi, Jeramie D Watrous and 8 more

Open access · goldAbstract readReview
In one paragraph

Review in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Integrating multi-omics and machine learning for disease resistance prediction in legumes.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2025
    Review
  12. Stimulant Use, HIV, and Plasma Metabolites Among Men.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  13. Article
  14. Article
  15. Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Joseph AntonelliDepartment of Statistics, University of Florida, Gainesville, FL 32611, USA.
Brian L ClaggettCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Mir HenglinCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Andy KimCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-0395-9471
Gavin OvsakCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Nicole KimCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Katherine DengCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Kevin RaoCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Octavia TyagiCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Jeramie D WatrousDepartments of Medicine & Pharmacology, University of California San Diego, La Jolla, CA 92093, USA.
Kim A LagerborgSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Pavel V HushchaCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Olga V DemlerPreventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Samia MoraCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-6283-0980
Teemu J NiiranenNational Institute for Health and Welfare, FI 00271 Helsinki, Finland.
Alexandre C PereiraDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Mohit JainSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. mjain@ucsd.edu.
Susan ChengCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. susan.cheng@cshs.org.
Brigham and Women's Hospital · USCedars-Sinai Medical Center · USHarvard University · USTurku University Hospital · FIUniversity of California San Diego · US

Funding

GRADUATE TRAINING IN BIOSTATISTICST32ES007142 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Brent Andrew Coull · 1985 to 2026
$11.9M
Reducing Inflammation for the Prevention of CVD: A Focus on Eicosanoid PathwaysR01HL134811 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MORA, SAMIA · 2017 to 2020
$3.0M
Circulating plasma metabolites, diet, and risk of type 2 diabetesR01DK112940 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI HU, FRANK B, MORA, SAMIA · 2018 to 2021
$2.9M
Patient Centered Approaches to Preventing ASCVD EventsK24HL136852 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SAMIA MORA · 2018 to 2026
$1.1M
CHD Risk and Metabolomic Profiles of Discordant LipidsK01HL135342 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMLER, OLGA · 2017 to 2021
$857k
Microbial contributions to the host metabolomeK01DK116917 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WATROUS, JERAMIE DEAN · 2018 to 2021
$648k
NHLBI NIH HHS K01 HL135342NHLBI NIH HHS K24 HL136852NHLBI NIH HHS R01 HL134811NIDDK NIH HHS K01 DK116917NIDDK NIH HHS R01 DK112940NIEHS NIH HHS T32 ES007142NIH HHS K01-HL135342NIH HHS R01-HL134168NIH HHS R01-HL134811NIH HHS T32-ES007142
6 · The paper itself

Abstract

High-throughput metabolomics investigations, when conducted in large human cohorts, represent a potentially powerful tool for elucidating the biochemical diversity underlying human health and disease. Large-scale metabolomics data sources, generated using either targeted or nontargeted platforms, are becoming more common. Appropriate statistical analysis of these complex high-dimensional data will be critical for extracting meaningful results from such large-scale human metabolomics studies. Therefore, we consider the statistical analytical approaches that have been employed in prior human metabolomics studies. Based on the lessons learned and collective experience to date in the field, we offer a step-by-step framework for pursuing statistical analyses of cohort-based human metabolomics data, with a focus on feature selection. We discuss the range of options and approaches that may be employed at each stage of data management, analysis, and interpretation and offer guidance on the analytical decisions that need to be considered over the course of implementing a data analysis workflow. Certain pervasive analytical challenges facing the field warrant ongoing focused research. Addressing these challenges, particularly those related to analyzing human metabolomics data, will allow for more standardization of as well as advances in how research in the field is practiced. In turn, such major analytical advances will lead to substantial improvements in the overall contributions of human metabolomics investigations.

Indexed as

high-dimensional datalarge-scale metabolomicsstatistical methods

Identifiers

PMID31336989
PMCPMC6680705
OpenAlexW2959053591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.